Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81−0.00 (-0.17%)
Close on Nov 12, 2026Market cap $9.43MP/E –Yield –
Phio Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Phio Pharmaceuticals's cash was $10.61M at Sep 30, 2026. For fiscal 2025 it was $21.03M, up 290.8% from the year before. Over ten years it grew 15.1% a year on average. The highest annual figure on record is $24.11M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.03M | +290.8% |
| FY2024 | Dec 31, 2024 | $5.38M | -36.6% |
| FY2023 | Dec 31, 2023 | $8.49M | -28.2% |
| FY2022 | Dec 31, 2022 | $11.83M | -50.9% |
| FY2021 | Dec 31, 2021 | $24.11M | +68.7% |
| FY2020 | Dec 31, 2020 | $14.29M | +104.7% |
| FY2019 | Dec 31, 2019 | $6.98M | -53.2% |
| FY2018 | Dec 31, 2018 | $14.93M | +311.2% |
| FY2017 | Dec 31, 2017 | $3.63M | -72.0% |
| FY2016 | Dec 31, 2016 | $12.96M | +150.7% |
| FY2015 | Dec 31, 2015 | $5.17M | -39.2% |
| FY2014 | Dec 31, 2014 | $8.50M | -41.0% |
| FY2013 | Dec 31, 2013 | $14.39M | +180.7% |
| FY2012 | Dec 31, 2012 | $5.13M | +919.3% |
| FY2011 | Dec 31, 2011 | $503.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.61M | -0.9% |
| Q2 FY2026 | Jun 30, 2026 | $13.00M | +20.6% |
| Q1 FY2026 | Mar 31, 2026 | $17.03M | +28.3% |
| Q4 FY2025 | Dec 31, 2025 | $21.03M | +290.8% |
| Q3 FY2025 | Sep 30, 2025 | $10.71M | +98.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.78M | +129.4% |
| Q1 FY2025 | Mar 31, 2025 | $13.28M | +105.1% |
| Q4 FY2024 | Dec 31, 2024 | $5.38M | -36.6% |
| Q3 FY2024 | Sep 30, 2024 | $5.39M | -35.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.70M | -58.5% |
| Q1 FY2024 | Mar 31, 2024 | $6.48M | -28.3% |
| Q4 FY2023 | Dec 31, 2023 | $8.49M | -28.2% |
| Q3 FY2023 | Sep 30, 2023 | $8.41M | -42.0% |
| Q2 FY2023 | Jun 30, 2023 | $11.31M | -37.3% |
| Q1 FY2023 | Mar 31, 2023 | $9.04M | -55.8% |
| Q4 FY2022 | Dec 31, 2022 | $11.83M | -50.9% |
| Q3 FY2022 | Sep 30, 2022 | $14.48M | -45.4% |
| Q2 FY2022 | Jun 30, 2022 | $18.02M | -38.8% |
| Q1 FY2022 | Mar 31, 2022 | $20.46M | -37.4% |
| Q4 FY2021 | Dec 31, 2021 | $24.11M | +68.7% |
| Q3 FY2021 | Sep 30, 2021 | $26.53M | +56.8% |
| Q2 FY2021 | Jun 30, 2021 | $29.43M | +55.6% |
| Q1 FY2021 | Mar 31, 2021 | $32.70M | +145.2% |
| Q4 FY2020 | Dec 31, 2020 | $14.29M | +104.7% |
| Q3 FY2020 | Sep 30, 2020 | $16.92M | +93.1% |
| Q2 FY2020 | Jun 30, 2020 | $18.91M | +74.1% |
| Q1 FY2020 | Mar 31, 2020 | $13.33M | +4.2% |
| Q4 FY2019 | Dec 31, 2019 | $6.98M | -53.2% |
| Q3 FY2019 | Sep 30, 2019 | $8.76M | +166.2% |
| Q2 FY2019 | Jun 30, 2019 | $10.87M | +102.5% |
| Q1 FY2019 | Mar 31, 2019 | $12.80M | +381.8% |
| Q4 FY2018 | Dec 31, 2018 | $14.93M | +311.2% |
| Q3 FY2018 | Sep 30, 2018 | $3.29M | -39.8% |
| Q2 FY2018 | Jun 30, 2018 | $5.37M | -30.8% |
| Q1 FY2018 | Mar 31, 2018 | $2.66M | -74.1% |
| Q4 FY2017 | Dec 31, 2017 | $3.63M | -72.0% |
| Q3 FY2017 | Sep 30, 2017 | $5.47M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.26M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.96M | – |
See a number that looks wrong?